Complete financial analysis of Circassia Group Plc (CIR.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Circassia Group Plc, a leading company in the Medical – Devices industry within the Healthcare sector.
- Japan Power Fastening Co.,Ltd. (5950.T) Income Statement Analysis – Financial Results
- Hebei Huijin Group Co., Ltd. (300368.SZ) Income Statement Analysis – Financial Results
- Pretium Resources Inc. (PVG.TO) Income Statement Analysis – Financial Results
- Tasty Bite Eatables Limited (TASTYBIT.BO) Income Statement Analysis – Financial Results
- BioDelivery Sciences International, Inc. (BDSI) Income Statement Analysis – Financial Results
Circassia Group Plc (CIR.L)
About Circassia Group Plc
Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.90M | 23.90M | 62.40M | 48.30M | 46.30M | 23.10M | 10.80M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 8.90M | 7.60M | 16.20M | 8.90M | 10.00M | 8.00M | 4.30M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 19.00M | 16.30M | 46.20M | 39.40M | 36.30M | 15.10M | 6.50M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 68.10% | 68.20% | 74.04% | 81.57% | 78.40% | 65.37% | 60.19% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 4.60M | 6.80M | 19.10M | 10.80M | 60.40M | 42.30M | 46.80M | 38.57M | 21.10M | 16.49M | 13.20M |
| General & Administrative | 6.80M | 10.20M | 12.60M | 11.40M | 11.00M | 15.40M | 13.70M | 7.24M | 3.82M | 2.65M | 2.15M |
| Selling & Marketing | 11.90M | 16.60M | 57.50M | 54.40M | 49.60M | 28.90M | 13.50M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 18.70M | 26.80M | 70.10M | 65.80M | 60.60M | 44.30M | 27.20M | 7.24M | 3.82M | 2.65M | 2.15M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 23.30M | 33.60M | 89.20M | 76.60M | 121.00M | 86.60M | 74.00M | 45.81M | 24.92M | 19.14M | 15.35M |
| Cost & Expenses | 32.20M | 41.20M | 105.40M | 85.50M | 131.00M | 94.60M | 78.30M | 45.81M | 24.92M | 19.14M | 15.35M |
| Interest Income | 0.00 | 100.00K | 200.00K | 300.00K | 400.00K | 900.00K | 1.70M | 1.75M | 606.00K | 836.00K | 132.00K |
| Interest Expense | 100.00K | 100.00K | 18.60M | 11.90M | 2.70M | 100.00K | 100.00K | 2.00K | 10.00K | 12.00K | 11.00K |
| Depreciation & Amortization | 4.90M | 9.00M | 15.20M | 4.40M | 4.90M | 5.30M | 2.90M | 24.00K | 1.03M | 554.00K | 260.00K |
| EBITDA | 4.20M | -16.00M | -25.30M | -110.00M | -112.50M | -139.40M | -59.80M | -43.96M | -23.88M | -18.59M | -15.09M |
| EBITDA Ratio | 15.05% | -66.95% | -40.54% | -227.74% | -242.98% | -603.46% | -553.70% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -700.00K | -25.00M | -40.50M | -114.40M | -117.40M | -144.70M | -62.70M | -43.99M | -24.92M | -19.14M | -15.35M |
| Operating Income Ratio | -2.51% | -104.60% | -64.90% | -236.85% | -253.56% | -626.41% | -580.56% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.40M | 6.60M | -18.60M | 58.60M | 3.80M | -200.00K | -100.00K | -2.00K | 1.02M | 542.00K | 249.00K |
| Income Before Tax | -2.10M | -18.40M | -59.10M | -55.80M | -113.60M | -144.90M | -62.80M | -43.99M | -23.89M | -18.60M | -15.10M |
| Income Before Tax Ratio | -7.53% | -76.99% | -94.71% | -115.53% | -245.36% | -627.27% | -581.48% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -4.40M | 8.40M | -10.80M | -9.20M | -21.00M | -7.50M | -12.80M | -8.88M | -3.91M | -3.10M | -590.00K |
| Net Income | 2.30M | -26.80M | -48.30M | -46.60M | -92.60M | -137.40M | -50.00M | -35.11M | -19.98M | -15.50M | -14.51M |
| Net Income Ratio | 8.24% | -112.13% | -77.40% | -96.48% | -200.00% | -594.81% | -462.96% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.01 | -0.07 | -0.13 | -0.14 | -0.29 | -0.48 | -0.20 | -0.21 | -0.11 | -0.08 | -0.08 |
| EPS Diluted | 0.01 | -0.07 | -0.13 | -0.14 | -0.29 | -0.48 | -0.20 | -0.21 | -0.11 | -0.08 | -0.08 |
| Weighted Avg Shares Out | 436.64M | 381.86M | 373.70M | 344.35M | 319.54M | 284.89M | 249.58M | 169.12M | 187.42M | 187.42M | 187.42M |
| Weighted Avg Shares Out (Dil) | 436.64M | 381.86M | 373.70M | 344.35M | 319.54M | 284.89M | 249.58M | 169.12M | 187.42M | 187.42M | 187.42M |
Source: https://incomestatements.info
Category: Stock Reports